| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Endocrinology, Vol 131, 1643-1649, Copyright © 1992 by Endocrine Society
ARTICLES |
A Hurwitz, ER Hernandez, DW Payne, AM Dharmarajan and EY Adashi
Department of Obstetrics/Gynecology, University of Maryland School of Medicine, Baltimore 21201.
An increasing body of information now suggests that intraovarian interleukin-1 (IL-1) may play an intermediary role in the ovulatory process. Given that follicular rupture inevitably requires marked tissue remodeling and possibly cell death, we set out to examine the morphogenic potential of IL-1 under in vitro circumstances. Treatment of freshly plated whole ovarian dispersates from immature rats with any one of several batches of IL-1 (10 ng/ml) for up to 96 h produced marked time-dependent morphological alterations, including cellular retraction, rounding, clumping, aggregation, blebbing, swelling, and, ultimately, irreversible detachment. Evidence of (asynchronous) cell death consisted of reduced total cell number, diminished cellular protein content, enhanced cellular release of lactic dehydrogenase, failure to exclude trypan blue, and attenuated reduction of the tetrazolium dye 3-[4,5-dimethylthiazol-2-y]2,5-diphenyltetrazolium bromide to spectrophotometrically detectable formazan. Comparable results were obtained when using established day 4 cultures, arguing against a possible critical action of IL-1 at the time of plating. Dose- response curves revealed IL-1 beta (EC50, 0.2-0.4 ng/ml) to be substantially more potent than IL-1 alpha (EC50, 2.7-2.8 ng/ml). Importantly, the concurrent provision of an IL-1 beta-directed polyclonal antibody yielded complete immunoneutralization of the IL-1 beta effect, arguing against the possible involvement of a non-IL-1 contaminant. An unrelated polyclonal antiserum raised against insulin- like growth factor-I was without effect. IL-1 action proved relatively specific, in that tumor necrosis factor-alpha (10 ng/ml), a putative cytotoxic principle, as well as IL-1-inducible ILs (IL-2 and -6; 100 U/ml) were without effect. Although minimally effective at the level of the isolated granulosa or theca-interstitial cell, IL-1 proved highly potent in heterologous (but not homologous), contact-dependent and independent cocultures of these somatic cell types, strongly suggesting obligatory cell-cell cooperation. These observations further indicate that IL-1 action is indirect and may require the induction of an intermediary soluble principle to serve as the final effector. Taken together, these findings indicate that relatively low concentrations of IL-1 (beta >> alpha), possible of somatic ovarian cell or resident ovarian macrophage origin, are capable of exerting specific dose- and time-dependent (immunoneutralizable) morphogenic as well as cytotoxic effects at the level of ovarian cells.(ABSTRACT TRUNCATED AT 400 WORDS)
This article has been cited by other articles:
![]() |
E. Houdeau, M. Larauche, R. Monnerie, L. Bueno, and J. Fioramonti Uterine motor alterations and estrous cycle disturbances associated with colonic inflammation in the rat Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2005; 288(3): R630 - R637. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Levitas, D. Chamoun, L. C. Udoff, M. Ando, C. E. Resnick, and E. Y. Adashi Periovulatory and Interleukin-1{beta}-Dependent Up-Regulation of Intraovarian Vascular Endothelial Growth Factor (VEGF) in the Rat: Potential Role for VEGF in the Promotion of Periovulatory Angiogenesis and Vascular Permeability Reproductive Sciences, January 1, 2000; 7(1): 51 - 60. [Abstract] [PDF] |
||||
![]() |
S. Kol, B. W. Donesky, K. Ruutiainen-Altman, I. Ben-Shlomo, M. Irahara, M. Ando, R. M. Rohan, and E. Y. Adashi Ovarian Interleukin-1 Receptor Antagonist in Rats: Gene Expression, Cellular Localization, Cyclic Variation, and Hormonal Regulation of a Potential Determinant of Interleukin-1 Action Biol Reprod, July 1, 1999; 61(1): 274 - 282. [Abstract] [Full Text] |
||||
![]() |
M. Ando, S. Kol, E. Kokia, K. Ruutiainen-Altman, J. Sirois, R. M. Rohan, D. W. Payne, and E. Y. Adashi Rat Ovarian Prostaglandin Endoperoxide Synthase-1 and -2: Periovulatory Expression of Granulosa Cell-Based Interleukin-1-Dependent Enzymes Endocrinology, May 1, 1998; 139(5): 2501 - 2508. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Y. Adashi, C. E. Resnick, D. W. Payne, R. G. Rosenfeld, T. Matsumoto, M. K. Hunter, S. E. Gargosky, J. Zhou, and C. A. Bondy The Mouse Intraovarian Insulin-Like Growth Factor I System: Departures from the Rat Paradigm Endocrinology, September 1, 1997; 138(9): 3881 - 3890. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. McGee, N. Spears, S. Minami, S.-Y. Hsu, S.-Y. Chun, H. Billig, and A. J. W. Hsueh Preantral Ovarian Follicles in Serum-Free Culture: Suppression of Apoptosis after Activation of the Cyclic Guanosine 3',5'-Monophosphate Pathway and Stimulation of Growth and Differentiation by Follicle-Stimulating Hormone Endocrinology, June 1, 1997; 138(6): 2417 - 2424. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Tabraue, R. D. Penate, G. Gallardo, I. Hernandez, J. Quintana, F. L. Blanco, J. G. Reyes, L. F. Fanjul, and C. M. Ruiz de Galarreta Induction of Guanosine Triphosphate-Cyclohydrolase by Follicle-Stimulating Hormone Enhances Interleukin-1{beta}-Stimulated Nitric Oxide Synthase Activity in Granulosa Cells Endocrinology, January 1, 1997; 138(1): 162 - 168. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Hurwitz, Z. Finci-Yeheskel, M. Dushnik, A. Milwidsky, S. Shimonovitz, S. Yagel, E. Y. Adashi, and M. Mayer Interleukin-1-Mediated Regulation of Plasminogen Activation in Pregnant Mare Serum Gonadotropin-Primed Rat Granulosa Cells Is Independent of Prostaglandin Production Reproductive Sciences, September 1, 1995; 2(5): 691 - 699. [Abstract] [PDF] |
||||
![]() |
D. W. Payne, C. Shackleton, H. Toms, I. Ben-Shlomo, S. Kol, M. deMoura, J. F. Strauss, and E. Y. Adashi A Novel Nonhepatic Hydroxycholesterol 7alpha-Hydroxylase That Is Markedly Stimulated by Interleukin-1beta J. Biol. Chem., August 11, 1995; 270(32): 18888 - 18896. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |